Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new release of the study page.SummaryDifference0.0%

- Check28 days agoChange DetectedThe Taiwan location in the study's locations list was updated from Taoyuan District to Taoyuan, Taiwan, 33305. This corrects the geographic designation used for that site in the trial record.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page’s revision identifier was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check64 days agoChange Detected- Added the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-facing content changes are evident.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.